This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 October – 11 November 2023 and includes updates on SARS-CoV-2 variants,

This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 October 2023 and includes updates on poliomyelitis, SARS-CoV-2, West Nile virus,

ECDC and World Health Organization (WHO) Regional Office for Europe have jointly developed the European Respiratory Virus Surveillance Summary (ERVISS), an interactive surveillance data dashboard

This interactive dashboard provides a weekly integrated epidemiological summary for influenza, respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-22 October 2023 and includes updates on respiratory virus epidemiology in the

This report is based on the findings from two focused After-Action reviews (AARs) in Norway and Georgia that discussed the use of evidence in the

This handbook provides an overview of commonly used laboratory protocols for the characterisation of SARS-CoV-2 and influenza viruses, provided by the AURORAE consortium.

Report from the after-action review (AAR) in Norway during the emergence of the Omicron variant of concern of SARS-CoV-2.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 October 2023 and includes updates on hepatitis A, influenza A(H5N1), COVID-19,

WHO/Europe, the European Commission and ECDC urge eligible groups to get vaccinated or boosted to save lives this autumn and winter.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 – 7 October 2023 and includes updates on dengue, West Nile